A real-world study of effectiveness of eribulin therapy in sub-group of metastatic breast cancer patients (elderly, African Americans, and patients with liver metastases)
Latest Information Update: 25 Jan 2021
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer; Liver metastases
- Focus Therapeutic Use
- 25 Jan 2021 New trial record
- 11 Dec 2020 Results presented at the 43rd Annual San Antonio Breast Cancer Symposium